HIV Protease Inhibitors [MoA]

Known as: HIV Protease Inhibitors, Human Immunodeficiency Virus Protease Inhibitors 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2015
024619962015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Lamin A (LMNA)-linked lipodystrophies may be either genetic (associated with LMNA mutations) or acquired (associated with the use… (More)
Is this relevant?
2009
2009
A major concern regarding the chronic administration of antiretroviral drugs is the potential for induction of drug efflux… (More)
Is this relevant?
2007
2007
Human immunodeficiency virus protease inhibitors (PIs) modestly affect the plasma pharmacokinetics of tenofovir (TFV; -15% to +37… (More)
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
2006
2006
Glioblastomas are malignant brain tumors that are rarely curable, even with aggressive therapy (surgery, chemotherapy, and… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Breast cancer resistance protein (BCRP) is a recently discovered ATP-binding cassette drug transporter. Hence, the full spectrum… (More)
Is this relevant?
2004
2004
BACKGROUND Although recommended as initial therapy for patients with dyslipidemia who are taking human immunodeficiency virus… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Human immunodeficiency virus protease inhibitors (HIV PIs) are associated with hyperlipidemia, hyperglycemia, and… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2000
2000
BACKGROUND Pharmacologic treatment of emotional disorders in HIV-infected patients can be more easily optimized by understanding… (More)
Is this relevant?
2000
2000
Polymorphonuclear leukocytes (PMNL) from human immunodeficiency virus (HIV)-infected patients exhibit accelerated apoptosis and… (More)
  • figure 1
  • table 1
Is this relevant?
1998
1998
OBJECTIVE To assess the pharmacokinetic interaction between ritonavir and saquinavir. METHODS Ritonavir and saquinavir were… (More)
Is this relevant?